Articles dans des revues avec comité de lecture (68)
  1. 1. Vandenbempt, V., Negueruela Escudero, J., Ribeiro-Costa, F., Nunes, M., Traini, L., Eski, S. E., St-Pierre-Wijckmans, W., Demine, S., Baeyens, N., Ibrahim, H., Martelotto, L. G., Singh, S. P., Cardozo, A. K., Bansal, M., & Gurzov, E. N. (2026). PTPN2 deficiency amplifies inflammatory signalling and impairs functional maturation of human stem cell-derived islets. Stem cell research & therapy. doi:10.1186/s13287-025-04892-4
  2. 2. Tiezzi, M., Haddad, C., Shahini, D., Mekouar, A., Mancuso, P., Van Praet, A., Sarkis, A.-S., Benhadou, F., Daoud, M., Suppa, M., Lemogoum, S., Motulsky, E., Cardozo, A. K., Del Marmol, V., & Borne, P. V. D. P. (2025). Exploring Vascular Homeostasis and Early Endothelial Damage in Hidradenitis Suppurativa: A Pilot Study on Erasmus Hospital Cohort. Journal of investigative dermatology. doi:10.1016/j.jid.2025.05.040
  3. 3. Lavis, P., Garabet, A., Cardozo, A. K., & Bondue, B. (2024). The fibroblast activation protein alpha as a biomarker of pulmonary fibrosis. Frontiers in medicine, 11. doi:10.3389/fmed.2024.1393778
  4. 4. Veli, Ö., Kaya, Ö., Varanda, A. B., Hildebrandt, X., Xiao, P., Estornes, Y., Poggenberg, M., Wang, Y., Pasparakis, M., Bertrand, M. J., Walczak, H., Annibaldi, A., Cardozo, A. K., & Peltzer, N. (2024). RIPK1 is dispensable for cell death regulation in β-cells during hyperglycemia. Molecular metabolism, 87, 101988. doi:10.1016/j.molmet.2024.101988
  5. 5. Blanc, M., Habbouche, L., Xiao, P., Lebeaupin, C., Janona, M., Vaillant, N., Irondelle, M., Gilleron, J., Murcy, F., Rousseau, D., Luci, C., Barouillet, T., Marchetti, S., Lacas-Gervais, S., Yvan-Charvet, L., Gual, P., Cardozo, A. K., & Bailly Maître, B. (2024). Bax Inhibitor-1 preserves pancreatic β-cell proteostasis by limiting proinsulin misfolding and programmed cell death. Cell death & disease, 15(5), 334. doi:10.1038/s41419-024-06701-x
  6. 6. Lavis, P., Bondue, B., & Cardozo, A. K. (2024). The Dual Role of Chemerin in Lung Diseases. Cells, 13(2), 171. doi:10.3390/cells13020171
  7. 7. Vandenbempt, V., Eski, S. E., Brahma, M. K., Li, A., Negueruela Escudero, J., Bruggeman, Y., Demine, S., Xiao, P., Cardozo, A. K., Baeyens, N., Martelotto, L., Singh, S. P., Mariño, E., Gysemans, C., & Gurzov, E. N. (2023). HAMSAB diet ameliorates dysfunctional signaling in pancreatic islets in autoimmune diabetes. iScience, 27(1), 108694. doi:10.1016/j.isci.2023.108694
  8. 8. Lavis, P., Pingitore, J., Doumont, G., Garabet, A., Van Simaeys, G., Lacroix, S., Passon, N., Van Heymbeek, C., De Maeseneire, C., Allard, J., Collin, A., Huaux, F., Decaestecker, C., Salmon, I., Goldman, S., Cardozo, A. K., & Bondue, B. (2023). Usefulness of FAPα assessment in bronchoalveolar lavage as a marker of fibrogenesis: results of a preclinical study and first report in patients with idiopathic pulmonary fibrosis. Respiratory research, 24(1), 254. doi:10.1186/s12931-023-02556-6
  9. 9. Takiishi, T., Xiao, P., Franchimont, M., Gilglioni, E. H., Arroba, E., Gurzov, E. N., Bertrand, M., & Cardozo, A. K. (2023). Inhibition of RIPK1 kinase does not affect diabetes development: β-Cells survive RIPK1 activation. Molecular metabolism, 69, 101681. doi:10.1016/j.molmet.2023.101681
  10. 10. Lavis, P., Morra, S., Orte Cano, C., Albayrak, N., Corbiere, V., Olislagers, V., Dauby, N., Del Marmol, V., Marchant, A., Decaestecker, C., Mascart, F., De Vos, N., Van De Borne, P., Salmon, I., Remmelink, M., Parmentier, M., Cardozo, A. K., & Bondue, B. (2022). Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality. Frontiers in immunology, 13, 941663. doi:10.3389/fimmu.2022.941663
  11. 11. Brahma, M. K., Xiao, P., Popa, M., Negueruela Escudero, J., Vandenbempt, V., Demine, S., Cardozo, A. K., & Gurzov, E. N. (2022). Nova1 or Bim Deficiency in Pancreatic β-Cells Does Not Alter Multiple Low-Dose Streptozotocin-Induced Diabetes and Diet-Induced Obesity in Mice. Nutrients, 14(18). doi:10.3390/nu14183866
  12. 12. Xiao, P., Takiishi, T., Moretti Violato, N., Licata, G., Dotta, F., Sebastiani, G., MARSELLI, L., Singh, S. P., Sze, M., Van Loo, G., Dejardin, E., Gurzov, E. N., & Cardozo, A. K. (2022). NF-kappaB-inducing kinase (NIK) is activated in pancreatic beta-cells but does not contribute to the development of diabetes. Cell death & disease, 13(5). doi:10.1038/s41419-022-04931-5
    13. << Précédent 1 2 3 4 5 6 7 Suivant >>